In 2012, Henning et al. demonstrated that using aqueous-brewed green tea extract decreased VEGF (Vascular Endothelial Growth Factor) in mice with prostate cancer cell subcutaneous xenografts. This evidence concerns the gene VEGFA and prostate carcinoma.